Latest News, Press Releases & Events

Spyryx Biosciences Announces CFFT Development Award

Spyryx Biosciences Receives Development Award from Cystic Fibrosis Foundation Therapeutics to Advance Novel Therapy for CF Durham, NC; June 25, 2015 – Spyryx Biosciences, Inc., a privately-held biopharmaceutical company developing novel therapeutics for obstructive lung diseases, announced today it has received an award from Cystic Fibrosis Foundation Therapeutics, which will support development of Spyryx’ therapeutic […]

Continue Reading

Spyryx Biosciences Appoints Timothy Crowder, PhD as Vice President, Technical Operations

Research Triangle Park, NC; June 15, 2015 – Spyryx Biosciences, Inc., a privately-held biopharmaceutical company developing novel therapeutics for respiratory diseases, including cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), announced today that it has appointed Timothy Crowder, PhD as its VP, Technical Operations. In this role, Dr. Crowder will be responsible for inhalation […]

Continue Reading